Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

IM Cannabis (IMCC) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for IM Cannabis (IMCC) over the last 6 years, with Q3 2025 value amounting to $8.1 million.

  • IM Cannabis' Cost of Revenue rose 265.4% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.7 million, marking a year-over-year decrease of 1221.73%. This contributed to the annual value of $33.3 million for FY2024, which is 1828.58% up from last year.
  • As of Q3 2025, IM Cannabis' Cost of Revenue stood at $8.1 million, which was up 265.4% from $6.7 million recorded in Q2 2025.
  • In the past 5 years, IM Cannabis' Cost of Revenue registered a high of $10.2 million during Q2 2024, and its lowest value of $3.3 million during Q1 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $7.2 million (2023), whereas its average is $7.2 million.
  • In the last 5 years, IM Cannabis' Cost of Revenue surged by 58449.27% in 2021 and then tumbled by 3419.06% in 2025.
  • Quarter analysis of 5 years shows IM Cannabis' Cost of Revenue stood at $7.0 million in 2021, then rose by 22.69% to $8.6 million in 2022, then fell by 18.13% to $7.0 million in 2023, then grew by 8.36% to $7.6 million in 2024, then increased by 5.91% to $8.1 million in 2025.
  • Its Cost of Revenue stands at $8.1 million for Q3 2025, versus $6.7 million for Q2 2025 and $6.3 million for Q1 2025.